歡迎來(lái)到上海通蔚!

021-54845833/15800441009

品質(zhì)保證 · 通蔚試劑

當(dāng)前位置: 首頁(yè) > 科研產(chǎn)品 > 科研抗體 > 其他抗體 > SEMA4A 抗原(重組蛋白)
  • SEMA4A 抗原(重組蛋白)

    規(guī)格:
    數(shù)量:

    購(gòu)買數(shù)量

    價(jià)格:
    • 品牌 : 通蔚生物
    • 目錄號(hào) : TW4819
    • 應(yīng)用 : 僅供科研使用
    • 保存條件 : 低溫保存
    • 貨期 : 現(xiàn)貨
    • 商品庫(kù)存:20
  • 商品詳情
  • 參考文獻(xiàn)
  • 說(shuō)明書下載
  • 商品評(píng)論0
  • 相關(guān)產(chǎn)品

中文名稱: SEMA4A 抗原(重組蛋白)

英文名稱: SEMA4A Antigen (Recombinant Protein)

別     名: sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A; RP35; SEMB; SEMAB;

儲(chǔ)     存: 冷凍(-20℃)

相關(guān)類別:抗原

概     述

Fusion protein corresponding to C terminal 201 amino acids of human SEMA4A

技術(shù)規(guī)格

Full name:

sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A

Synonyms:

RP35; SEMB; SEMAB; CORD10

Swissprot:

Q9H3S1

Gene Accession:

BC020974

Purity:

>85%, as determined by Coomassie blue stained SDS-PAGE

Expression system:

Escherichia coli

Tags:

His tag C-Terminus, GST tag N-Terminus

Background:

This gene encodes a member of the semaphorin family of soluble and transmembrane proteins. Semaphorins are involved in numerous functions, including axon guidance, morphogenesis, carcinogenesis, and immunomodulation. The encoded protein is a single-pass type I membrane protein containing an immunoglobulin-like C2-type domain, a PSI domain and a sema domain. It inhibits axonal extension by providing local signals to specify territories inaccessible for growing axons. It is an activator of T-cell-mediated immunity and suppresses vascular endothelial growth factor (VEGF)-mediated endothelial cell migration and proliferation in vitro and angiogenesis in vivo. Mutations in this gene are associated with retinal degenerative diseases including retinitis pigmentosa type 35 (RP35) and cone-rod dystrophy type 10 (CORD10). Multiple alternatively spliced transcript variants encoding different isoforms have been identified.